SUBSCRIBE
SUBSCRIBE
News   Business

Oscient Pharmaceuticals Corporation Provides Financial Projections For Fiscal Year 2006 And 2007

December 8, 2006 | 
1 min read

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today provided fiscal year 2006 and 2007 revenue guidance for its products, ANTARA® 130 mg (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets.

Earnings
MORE ON THIS TOPIC
vintage textured collage with symbols of New York City
Tariffs
Biotech’s Next Phase Will Be All-American: Pitchbook
April 17, 2025
 · 
2 min read
 · 
Annalee Armstrong
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Artificial intelligence
Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics
April 17, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Find understanding between people. Reach your opponent. Building a bridge of understanding and reasoning. Discover common ground. Pave way for cooperation or peaceful disagreement. Resolving conflict
Mergers & acquisitions
Bluebird’s Second Suitor, Ayrmid, Fails To Produce an Offer
April 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
Rare diseases
Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year
April 16, 2025
 · 
2 min read
 · 
Dan Samorodnitsky